CTRI/2024/01/061498
Recruiting
未知
A Clinically-Oriented Antimicrobial Resistance Surveillance Network for Healthcare-associated infections - ACORN-HAI
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- The George Institute for Global Health
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Healthcare\-associated bloodstream infection
- •1\) Prescription/commencement of an intravenous antibiotic AND
- •2\) Positive growth of bacterial or Candida spp pathogen(s) identified from blood specimen(s) taken on or after day 3 of admission (Day 1 refers to the day of admission), or within 3 months of significant healthcare exposure; AND
- •3\) Bacterial pathogen(s) in the blood specimen(s) satisfies either of the following:
- •i) one or more non\-common commensal bacterial pathogen(s) identified from one or more blood specimens obtained by a culture; OR
- •ii) the same common commensal bacterial pathogen identified from two or more blood specimens collected on separate occasions
- •Ventilator\-associated pneumonia
- •1\) Clinical suspicion of VAP; AND
- •2\) Prescription/commencement of an intravenous antibiotic; AND
- •3\) Positive growth of bacterial pathogen(s) identified from respiratory specimen(s) taken on or after day 3 of ventilation.
Exclusion Criteria
- •Healthcare\-associated bloodstream infection
- •Patient who has positive growth of organisms belonging to the following genera which are typically causes of community\-associated infections and are rarely or are not known to be causes of healthcare\-associated infections, or associated with severe immune suppression:
- •a)Burkholderia pseudomallei,
- •b)Brucella spp, including but not limited to, B. melitensis, B. abortus, B. suis, B. canis,
- •c)Campylobacter, Salmonella, Shigella, Listeria, Vibrio and Yersinia.
- •Ventilator\-associated pneumonia
- •Patient who has positive growth of organisms belonging to the following genera which are typically causes of community\-associated infections and/or are rarely or are not known to be causes of healthcare\-associated infections:
- •a)Streptococcus pneumoniae, Streptococcus suis, Haemophilus influenzae,
- •b)Burkholderia pseudomallei,
- •c)Coagulase\-negative staphylococci,
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Clinical relevance of the antimicrobial resistance testing in the treatment of chronic wounds with antisepticsDecubitus, acute or chronic wounds (open wounds existing = 14 days)Therapeutic area: Diseases [C] - Bacterial Infections and Mycoses [C01]EUCTR2018-003321-29-DERWTH Aachen University represented by the Rector himself, represented by the Dean of the Medical Faculty
Not yet recruiting
Not Applicable
To study Antimicrobial resistance of intestinal micro flora in people working in medical setting and non-medical setting.CTRI/2020/03/024275Kasturba Medical College Manipal
Not yet recruiting
Not Applicable
Clinical predictive of antimicrobial resistance bacteremia at the Emergency Departmentantimicrobial resistance bacteremia antibiotic stewardshipTCTR20200909003Research Affairs, Faculty of Medicine, Khon Kaen University200
Completed
Not Applicable
Study of antimicrobial resistance in patients receiving outpatient parenteral antimicrobial therapyAntimicrobial resistance (AMR)Infections and InfestationsISRCTN15309500Cambridge University Hospitals NHS Foundation Trust40
Completed
Not Applicable
emergence of antibiotic resistanceapical periodontitisendodonticsTCTR20220118002scientific projects unit45